Joseph P. Tiano
About Joseph P. Tiano
Joseph P. Tiano is a Health Science Policy Analyst at the National Institutes of Health, where he has worked since 2021. He has a diverse background in health science policy and research, with previous roles at various NIH institutes and a strong academic foundation in life sciences and management.
Work at National Institutes of Health
Joseph P. Tiano has been employed as a Health Science Policy Analyst at the National Institutes of Health (NIH) since 2021. He works in Bethesda, Maryland, focusing on health science policy initiatives. Prior to this role, he served as an AAAS Science & Technology Policy Fellow at NIH from 2012 to 2016, where he spent 1.5 years in the Office of Strategic Coordination (The Common Fund). His experience at NIH spans over a decade, contributing to various projects and initiatives in health science policy.
Education and Expertise
Joseph P. Tiano holds a Doctor of Philosophy in Life Sciences from Northwestern University - The Feinberg School of Medicine, which he completed in 2012. His doctoral research focused on the protective effects of estrogens in rodent models of type-2 diabetes. He also earned a Graduate Teaching Certificate from the Northwestern University - Searle Center for Advancing Learning & Teaching in 2012. Additionally, he completed a Management for Scientists and Engineers Certificate Program at Northwestern University's Kellogg School of Management in 2011.
Background
Joseph P. Tiano began his academic journey at Duquesne University, where he earned a Bachelor of Science in Biology from 2002 to 2006. Following his undergraduate studies, he pursued advanced degrees at Northwestern University, culminating in a PhD. His early career included a postdoctoral fellowship at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) from 2012 to 2015, where he conducted research on the TGF-beta/Smad3 pathway and its implications for type 2 diabetes.
Professional Experience
Before his current role at NIH, Joseph P. Tiano worked as a Health Science Policy Analyst at the National Institute of Dental and Craniofacial Research (NIDCR) from 2017 to 2020. He also served as a Meetings Committee Member for the National Postdoctoral Association from 2013 to 2015. His diverse roles in various NIH institutes and organizations reflect his commitment to advancing health science policy and research.
Research Contributions
During his postdoctoral fellowship, Joseph P. Tiano contributed to significant research projects, including a small molecule inhibitor screen against the transcription factor SMAD3 aimed at discovering new treatments for type 2 diabetes. He also investigated the role of the hormone irisin in modulating skeletal muscle and white adipose tissue-browning, furthering the understanding of metabolic processes related to diabetes.